95 related articles for article (PubMed ID: 21308147)
1. A four-gene signature predicts disease progression in muscle invasive bladder cancer.
Kim WJ; Kim SK; Jeong P; Yun SJ; Cho IC; Kim IY; Moon SK; Um HD; Choi YH
Mol Med; 2011; 17(5-6):478-85. PubMed ID: 21308147
[TBL] [Abstract][Full Text] [Related]
2. CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.
Worst TS; Weis CA; Stöhr R; Bertz S; Eckstein M; Otto W; Breyer J; Hartmann A; Bolenz C; Wirtz RM; Erben P
Sci Rep; 2018 Sep; 8(1):14383. PubMed ID: 30258198
[TBL] [Abstract][Full Text] [Related]
3. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.
Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Alber G; Kiefer I; Steiner JM; Seeger J; Heilmann RM
BMC Vet Res; 2023 Nov; 19(1):234. PubMed ID: 37946179
[TBL] [Abstract][Full Text] [Related]
4. A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases.
Hu K; Hu X; Duan Y; Li W; Qian J; Chen J
Front Med (Lausanne); 2022; 9():815541. PubMed ID: 35783639
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.
Zhang Y; Lin Y; Lv D; Wu X; Li W; Wang X; Jiang D
PeerJ; 2022; 10():e12843. PubMed ID: 35127296
[TBL] [Abstract][Full Text] [Related]
6. Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.
Park S; Rong L; Owczarek TB; Bernardo MD; Shoulson RL; Chua CW; Kim JY; Lankarani A; Chakrapani P; Syed T; McKiernan JM; Solit DB; Shen MM; Al-Ahmadie HA; Abate-Shen C
Cancer Res; 2021 Oct; 81(20):5161-5175. PubMed ID: 34470779
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
[TBL] [Abstract][Full Text] [Related]
8. CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers.
Chen H; Liu Y; Cao C; Xi H; Chen W; Zheng W; Dong X; Zheng S; Li L; Ma J; Gao Y; Shou J
Ann Transl Med; 2021 May; 9(9):761. PubMed ID: 34268374
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of S100A8 in Human Solid Cancers: A Systematic Review and Validation.
Huang A; Fan W; Liu J; Huang B; Cheng Q; Wang P; Duan Y; Ma T; Chen L; Wang Y; Yu M
Front Oncol; 2020; 10():564248. PubMed ID: 33240811
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis related gene expression significantly associated with the prognostic role of an urothelial bladder carcinoma.
Wang J; Guo M; Zhou X; Ding Z; Chen X; Jiao Y; Ying W; Wu S; Zhang X; Geng N
Transl Androl Urol; 2020 Oct; 9(5):2200-2210. PubMed ID: 33209684
[TBL] [Abstract][Full Text] [Related]
11. Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.
Johnson RM; Phillips HS; Bais C; Brennan CW; Cloughesy TF; Daemen A; Herrlinger U; Jenkins RB; Lai A; Mancao C; Weller M; Wick W; Bourgon R; Garcia J
Neuro Oncol; 2020 Dec; 22(12):1742-1756. PubMed ID: 32897363
[TBL] [Abstract][Full Text] [Related]
12. A novel tumor suppressing gene,
Piao XM; Jeong P; Yan C; Kim YH; Byun YJ; Xu Y; Kang HW; Seo SP; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
Oncol Lett; 2020 Jan; 19(1):476-486. PubMed ID: 31897161
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer.
Zhang PB; Huang ZL; Xu YH; Huang J; Huang XY; Huang XY
Cancer Cell Int; 2019; 19():337. PubMed ID: 31866765
[TBL] [Abstract][Full Text] [Related]
14. A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection.
Li Y; Zhang H; Guo Y; Cai H; Li X; He J; Lai HM; Guan Q; Wang X; Guo Z
Front Oncol; 2019; 9():629. PubMed ID: 31355144
[No Abstract] [Full Text] [Related]
15. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
Nicklas AP; Kramer MW; Serth J; Hennenlotter J; Hupe MC; Reimer DU; Stenzl A; Merseburger AS; Kuczyk MA; von Klot CJ
Adv Ther; 2018 Nov; 35(11):2054-2068. PubMed ID: 30232708
[TBL] [Abstract][Full Text] [Related]
16. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
[TBL] [Abstract][Full Text] [Related]
17. The role of
Zhang W; Chen M; Cheng H; Shen Q; Wang Y; Zhu X
Cancer Manag Res; 2018; 10():323-338. PubMed ID: 29497331
[TBL] [Abstract][Full Text] [Related]
18. Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.
Lee MS; Lee J; Lee S; Yoo SM; Kim JH; Kim WT; Kim WJ; Park J
Oncotarget; 2018 Jan; 9(8):7961-7974. PubMed ID: 29487706
[TBL] [Abstract][Full Text] [Related]
19. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
